insights_auto
Kwa nini AGIO imepungua kwa 4.03%?
Fahamu zaidichevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ 27.60
arrow_downward
-4.03%(-1.16) Siku 1
US$ 27.60
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 20 Nov, 16:00:00 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AGIO...
Fungua
US$ 28.01
Juu
US$ 29.14
Chini
US$ 27.43
Mtaji wa soko
1.65B
Wastani wa kiasi cha mauzo
1.13M
Kiasi cha mauzo ya hisa
elfu 776.20
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Fungua
US$ 28.01
Juu
US$ 29.14
Chini
US$ 27.43
Mtaji wa soko
1.65B
Wastani wa kiasi cha mauzo
1.13M
Kiasi cha mauzo ya hisa
elfu 776.20
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Trefis
·
saa 1 iliyopita
25 S&P 500 Stocks Just Made New 52-Week Lows
Marietta Daily Journal
·
saa 10 zilizopita
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
RealMoney Pro
·
saa 11 zilizopita
The S&P 500’s Worst Week Since April 2025 Ends in a Correction
Yahoo Finance
·
saa 13 zilizopita
Wall St ends sharply lower on AI selloff, S&P 500, Dow in correction
Wasifu
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Kuhusu Agios Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi540
Lilianzishwa2008
Makao makuu-
SektaHealth Care
Sekta-
Tovutiagios.com